Table 2.
Target | Scoring method | |
---|---|---|
1 | 0 | |
Abdominal pain | Baseline: Mild, moderate or severe pain | (a) No abdominal pain; (b) degree of pain decreased from severe to mild |
Post‐FMT: Degree of pain from severe to moderate, from moderate to mild, unchanged or aggravated compared to baseline | ||
Diarrhoea | Baseline: Liquid stool | (a) No liquid stool; (b) frequency of liquid stool decreased from 2 to 1,> 2 to 0 ~ 2; (3) frequency of liquid stool decreased by 80% if > 10 |
Post‐FMT: Frequency of liquid stool unchanged or increased compared to baseline | ||
Hematochezia | Blood in the stool | No blood in the stool |
Fever | Fever (≥37.3 degree centigrade) | No fever (<37.3 degree centigrade) |
Steroid‐dependence | (a) Relapse within 3 months of stopping steroids; (b) unable to reduce steroids below the equivalent of prednisone 10 mg day−1 within 3 months of starting steroids, without recurrent active disease | (a) Clinical remission without use of steroids; (b) steroids ceased for more than 3 months without relapse |
Enterocutaneous fistula | Fistula drainage | (a) Closure of fistula; (b) no fistula drainage |
Active perianal fistula | Moderate or substantial mucous or purulent discharge | (a) Closure of fistula; (b) a reduction in the number of draining fistulas by 50% compared to baseline |
Definition: 1 = With any target at baseline; or matching any criteria for more than 20% of time between two serial assessment time points; 0 = Without target at baseline; or matching any criteria for more than 80% of time between two serial assessment time points.